SAINTE-FOY, QUEBEC--(Marketwire - October 10, 2007) - Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer and supplier of taxane APIs, is pleased to announce today that it has landed a significant paclitaxel order with a leading EU generic manufacturing company. The order, valued at $700,000, will be used in a generic paclitaxel drug already approved and marketed in Europe. Product deliveries under the order will begin in the present quarter.
